May 11, 2020; New York, NY –  OneOncology, the national partnership of independent community oncologists announced four oncology practices in Queens and Manhattan have chosen to join New York Cancer and Blood Specialists (NYCBS).

OneOncology helps partner practices expand their services along the continuum of cancer care from screening and diagnosis to clinical trials, therapies, survivorship, and end-of-life care. OneOncology technology, integration support, and capital enable NYCBS to create a partnership with these oncology practices, which allows the physicians to focus on patient care and clinical trial research.

“The addition of these physician practices in Queens and Manhattan showcase the value the OneOncology partnership brings to oncologists and their patients,” said Jeff Vacirca, MD, CEO, NYCBS, and Board Member, OneOncology. “With access to the expertise and resources a practice requires to care for patients today, OneOncology provides a way forward for oncologists who want to control their own future by remaining independent and who understand what it takes to operate a healthy practice.”

The four practices who are joining OneOncology are led by the following oncologists:

• Dr. Li-Teh Wu, Queens
• Dr. Arthur Goldberg, Manhattan
• Dr. Niculae Ciobanu, Manhattan
• Dr. Keith Brunckhorst, Manhattan

“Joining NYCBS and OneOncology has several advantages that deliver immense value to patients,” said Dr. Wu. “Having the ability to utilize a physician-led and tailored technology, analytics platform, and a clinical trial research network enhances my ability to provide care.”

NYCBS has innovated during the COVID-19 pandemic to continue caring for vulnerable cancer patients. The practice has implemented safety precautions, ramped up its telemedicine initiatives, and launched a “drive-thru” lab so patients don’t have to leave their cars to get their blood tested and can maintain proper social distancing. 

OneOncology, which was formed in 2018, consists of five prominent practices throughout the country.